Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-10-22-Speech-3-027"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20081022.2.3-027"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Commissioner, ladies and gentlemen, I would firstly like to pay tribute to the work of Mrs Grossetête and that of my fellow Members who worked on this report. This is a very important subject since it concerns our health. This report is a big step forward in harmonisation of the internal market, but also in consumer protection, especially for the elderly.
As Mr Verheugen stated, our population is living longer, which, of course, we are delighted about, but this is an issue set to grow in importance. When this directive is implemented, the indications appearing on a medicine will be identical in all Member States, providing clarity and transparency for European users, whether they are patients, veterinarians or farmers.
Likewise, with the implementation of a single procedure to apply for authorisations, this report will greatly contribute to simplifying current procedures on an administrative and technical level.
Indeed, it will no longer be necessary to submit 27 applications within the Member States. A single application to the European Medicines Agency will suffice. This report marks a further step towards European integration."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples